Ignite Creation Date:
2024-05-06 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03631836
Status:
UNKNOWN
Last Update Posted:
2018-08-17
First Post:
2018-08-13
Brief Title:
Phase I Study of Monoclonal Antibondy GS 5745 an Matix Metalloproteinase 9 MMP9 Mab Inhibitor in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
Sponsor:
Assistance Publique Hopitaux De Marseille
Organization:
Assistance Publique Hopitaux De Marseille
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-13
First Submit QC Date:
August 13 2018
Study First Post Date:
2018-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-16
Last Update Post Date:
2018-08-17
Last Update Post Date Type:
ACTUAL